Stefan Lorenzl, MD - Publications

Affiliations: 
Neurology Ludwig-Maximilians-Universität München, München, Bayern, Germany 

81 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Nuebling G, Hensler M, Paul S, Zwergal A, Crispin A, Lorenzl S. PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy. Journal of Neurology. PMID 27230855 DOI: 10.1007/s00415-016-8169-1  0.76
2016 Levin J, Maaß S, Schuberth M, Respondek G, Paul F, Mansmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning G, Giese A, Bötzel K, et al. The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26809243 DOI: 10.1007/s00702-016-1507-8  0.76
2015 Oliver DJ, Borasio GD, Caraceni A, de Visser M, Grisold W, Lorenzl S, Veronese S, Voltz R. A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. PMID 26423203 DOI: 10.1111/ene.12889  0.76
2015 Levin J, Bak TH, Rominger A, Mille E, Arzberger T, Giese A, Ackl N, Lorenzl S, Bader B, Patzig M, Bötzel K, Danek A. The association of aphasia and right-sided motor impairment in corticobasal syndrome. Journal of Neurology. 262: 2241-6. PMID 26143172 DOI: 10.1007/s00415-015-7833-1  0.76
2015 Sieb JP, Themann P, Warnecke T, Lauterbach T, Berkels R, Grieger F, Lorenzl S. Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study. Current Medical Research and Opinion. 31: 967-74. PMID 25772231 DOI: 10.1185/03007995.2015.1030376  0.76
2014 Huemer M, Bürer C, Ješina P, Kožich V, Landolt MA, Suormala T, Fowler B, Augoustides-Savvopoulou P, Blair E, Brennerova K, Broomfield A, De Meirleir L, Gökcay G, Hennermann J, Jardine P, ... ... Lorenzl S, et al. Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data. Journal of Inherited Metabolic Disease. PMID 25526710 DOI: 10.1007/s10545-014-9803-7  0.76
2014 Rémi C, Lorenzl S, Vyhnalek B, Rastorfer K, Feddersen B. Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects. Journal of Pain & Palliative Care Pharmacotherapy. 28: 371-7. PMID 25313924 DOI: 10.3109/15360288.2014.959234  0.76
2014 Bükki J, Unterpaul T, Nübling G, Jox RJ, Lorenzl S. Decision making at the end of life--cancer patients' and their caregivers' views on artificial nutrition and hydration. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 3287-99. PMID 25084741 DOI: 10.1007/s00520-014-2337-6  0.76
2014 Nübling GS, Levin J, Bader B, Lorenzl S, Hillmer A, Högen T, Kamp F, Giese A. Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers. Plos One. 9: e98906. PMID 24911099 DOI: 10.1371/journal.pone.0098906  0.76
2014 Boxer AL, Lang AE, Grossman M, Knopman DS, Miller BL, Schneider LS, Doody RS, Lees A, Golbe LI, Williams DR, Corvol JC, Ludolph A, Burn D, Lorenzl S, Litvan I, et al. Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. The Lancet. Neurology. 13: 676-85. PMID 24873720 DOI: 10.1016/S1474-4422(14)70088-2  0.76
2014 Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A, Rothenbacher D, Nagel G, Adam T, Arnold G, Baier H, Bäzner H, Beattie J, Behne F, Bengel D, ... ... Lorenzl S, et al. Incidence and geographical variation of Amyotrophic Lateral Sclerosis (als) in Southern Germany - Completeness of the ALS registry Swabia Plos One. 9. PMID 24722455 DOI: 10.1371/journal.pone.0093932  0.76
2014 Lorenzl S. [Multimorbidity of neurological patients in palliative care units]. Der Nervenarzt. 85: 409-16. PMID 24682167 DOI: 10.1007/s00115-013-3938-x  0.76
2014 Nübling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, Irwin DE, Borasio GD, Winkler AS. Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 15: 174-9. PMID 24479577 DOI: 10.3109/21678421.2013.868001  0.76
2014 Rosenbohm A, Kassubek J, Weydt P, Marroquin N, Volk AE, Kubisch C, Huppertz HJ, Weber M, Andersen PM, Weishaupt JH, Ludolph AC. Can lesions to the motor cortex induce amyotrophic lateral sclerosis? Journal of Neurology. 261: 283-90. PMID 24253481 DOI: 10.1007/s00415-013-7185-7  0.76
2014 Fegg MJ, Kögler M, Abright C, Hensler M, Lorenzl S. Meaning in life in patients with progressive supranuclear palsy. The American Journal of Hospice & Palliative Care. 31: 543-7. PMID 23785042 DOI: 10.1177/1049909113492411  0.76
2014 Lorenzl S. Intracranial pressure and epileptic seizures | Hirndruck und epileptische Anfälle Onkologe. 20: 261-266. DOI: 10.1007/s00761-013-2578-x  0.76
2013 Zech M, Nübling G, Castrop F, Jochim A, Schulte EC, Mollenhauer B, Lichtner P, Peters A, Gieger C, Marquardt T, Vanier MT, Latour P, Klünemann H, Trenkwalder C, Diehl-Schmid J, ... ... Lorenzl S, et al. Niemann-Pick C disease gene mutations and age-related neurodegenerative disorders. Plos One. 8: e82879. PMID 24386122 DOI: 10.1371/journal.pone.0082879  0.76
2013 Lorenzl S, Dieterich M. [Support to pass away]. Fortschritte Der Neurologie-Psychiatrie. 81: 677-8. PMID 24307085 DOI: 10.1055/s-0033-1356119  0.76
2013 Voltz R, Nübling G, Lorenzl S. Care of the dying neurologic patient. Handbook of Clinical Neurology. 118: 141-5. PMID 24182373 DOI: 10.1016/B978-0-444-53501-6.00011-1  0.76
2013 Lorenzl S, Nübling G, Perrar KM, Voltz R. Palliative treatment of chronic neurologic disorders. Handbook of Clinical Neurology. 118: 133-9. PMID 24182372 DOI: 10.1016/B978-0-444-53501-6.00010-X  0.76
2013 Mackenzie IR, Arzberger T, Kremmer E, Troost D, Lorenzl S, Mori K, Weng SM, Haass C, Kretzschmar HA, Edbauer D, Neumann M. Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations. Acta Neuropathologica. 126: 859-79. PMID 24096617 DOI: 10.1007/s00401-013-1181-y  0.76
2013 Lorenzl S. Infusion pumps in palliative care are vital, but many need updating. British Journal of Nursing (Mark Allen Publishing). 22: S4. PMID 24067272 DOI: 10.12968/bjon.2013.22.Sup17.S4  0.76
2013 Lorenzl S. In reply: Echocardiography is not a basic diagnostic test. Deutsches ÄRzteblatt International. 110: 9. PMID 23450988 DOI: 10.3238/arztebl.2013.0009  0.76
2013 Nagel G, Ünal H, Rosenbohm A, Ludolph AC, Rothenbacher D, Arnold G, Adam T, Neusch C, Bäzner H, Börtlein A, Baier H, Behne F, Raape J, Rothmeier J, Beattie J, ... ... Lorenzl S, et al. Implementation of a population-based epidemiological rare disease registry: Study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia Bmc Neurology. 13. PMID 23414001 DOI: 10.1186/1471-2377-13-22  0.76
2013 Zwergal A, la Fougère C, Lorenzl S, Rominger A, Xiong G, Deutschenbaur L, Schöberl F, Linn J, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K. Functional disturbance of the locomotor network in progressive supranuclear palsy. Neurology. 80: 634-41. PMID 23345641 DOI: 10.1212/WNL.0b013e318281cc43  0.76
2013 Lorenzl S. End of one's life-Decision making between autonomy and uncertainty Geriatric Mental Health Care. 1: 63-66. DOI: 10.1016/j.gmhc.2013.04.009  0.76
2012 Hensler M, Remi J, Nübling GS, Lorenzl S. Prospective evaluation of the frequency and treatment of restless legs syndrome in a palliative care unit. Journal of Pain and Symptom Management. 44: e3-5. PMID 23131706 DOI: 10.1016/j.jpainsymman.2012.07.016  0.76
2012 Nübling G, Allmendinger S, Lorenzl S. [Drug therapy of anxiety and fear in palliative care patients with cancer or other illnesses : a systematic review]. Schmerz (Berlin, Germany). 26: 537-49. PMID 22968367 DOI: 10.1007/s00482-012-1241-6  0.76
2012 Nübling G, Levin J, Bader B, Israel L, Bötzel K, Lorenzl S, Giese A. Limited cleavage of tau with matrix-metalloproteinase MMP-9, but not MMP-3, enhances tau oligomer formation. Experimental Neurology. 237: 470-6. PMID 22890115 DOI: 10.1016/j.expneurol.2012.07.018  0.76
2012 Lorenzl S, Füsgen I, Noachtar S. Acute confusional States in the elderly--diagnosis and treatment. Deutsches ÄRzteblatt International. 109: 391-9; quiz 400. PMID 22690255 DOI: 10.3238/arztebl.2012.0391  0.76
2012 Gold M, Lorenzl S, Stewart AJ, Morimoto BH, Williams DR, Gozes I. Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy. Neuropsychiatric Disease and Treatment. 8: 85-93. PMID 22347799 DOI: 10.2147/NDT.S12518  0.76
2011 Reichel CA, Uhl B, Lerchenberger M, Puhr-Westerheide D, Rehberg M, Liebl J, Khandoga A, Schmalix W, Zahler S, Deindl E, Lorenzl S, Declerck PJ, Kanse S, Krombach F. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor. Circulation. 124: 1848-59. PMID 21969013 DOI: 10.1161/CIRCULATIONAHA.110.017012  0.76
2011 Zwergal A, la Fougère C, Lorenzl S, Rominger A, Xiong G, Deutschenbaur L, Linn J, Krafczyk S, Dieterich M, Brandt T, Strupp M, Bartenstein P, Jahn K. Postural imbalance and falls in PSP correlate with functional pathology of the thalamus. Neurology. 77: 101-9. PMID 21613601 DOI: 10.1212/WNL.0b013e318223c79d  0.76
2011 Hensler M, Paul S, Abright C, Lorenzl S. [Progressive supranuclear palsy: living environment of the patients in Germany]. Der Nervenarzt. 82: 207-14. PMID 20669002 DOI: 10.1007/s00115-010-3076-7  0.76
2010 Levin J, Bötzel K, Giese A, Vogeser M, Lorenzl S. Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis. Dementia and Geriatric Cognitive Disorders. 29: 553-9. PMID 20606437 DOI: 10.1159/000314841  0.76
2010 Lorenzl S, Mayer S, Feddersen B, Jox R, Noachtar S, Borasio GD. Nonconvulsive status epilepticus in palliative care patients. Journal of Pain and Symptom Management. 40: 460-5. PMID 20594804 DOI: 10.1016/j.jpainsymman.2010.01.019  0.76
2010 Lorenzl S. Stem cells and the modeling of the extracellular matrix--the library of cells needs suitable bookshelves. Journal of Molecular Medicine (Berlin, Germany). 88: 531-3. PMID 20232193 DOI: 10.1007/s00109-010-0612-7  0.76
2010 Schmich J, Porsche J, Vogel M, Kuny R, Mannsberger U, Lorenzl S, Levin J, Ziegler W. Everyday communication in dysarthria: A self-report questionnaire | Alltags- und kommunikationsbezogene Dysarthriediagnostik: Ein Fragebogen zur Selbsteinschätzung Sprache Stimme Gehor. 34: 73-79. DOI: 10.1055/s-0030-1253383  0.76
2010 Borasio GD, Bausewein C, Lorenzl S, Voltz R, Wasner M. Palliative care in neuro-oncology Oncology of Cns Tumors. 783-788. DOI: 10.1007/978-3-642-02874-8_60  0.76
2010 Lorenzl S. Palliative care and Parkinson's disease | Palliative versorgung Nervenheilkunde. 29: 368-371.  0.76
2009 Lorenzl S. [Spiritual care for gravely ill patients]. Mmw Fortschritte Der Medizin. 151: 41-2. PMID 20088321  0.76
2009 Lorenzl S. [Parkinson's disease and atypical Parkinson syndromes]. Mmw Fortschritte Der Medizin. 151: 39-40. PMID 20088320  0.76
2009 Schneider M, Hoffmann M, Lorenzl S. Evaluating the use of the Cleo 90 infusion set for patients on a palliative care unit. International Journal of Palliative Nursing. 15: 372-6. PMID 19773700 DOI: 10.12968/ijpn.2009.15.8.43795  0.76
2009 Stanger O, Fowler B, Piertzik K, Huemer M, Haschke-Becher E, Semmler A, Lorenzl S, Linnebank M. Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendations. Expert Review of Neurotherapeutics. 9: 1393-412. PMID 19769453 DOI: 10.1586/ern.09.75  0.76
2009 Levin J, Giese A, Boetzel K, Israel L, Högen T, Nübling G, Kretzschmar H, Lorenzl S. Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases. Experimental Neurology. 215: 201-8. PMID 19022250 DOI: 10.1016/j.expneurol.2008.10.010  0.76
2008 Lorenzl S. [Vitamin B substitution. No protection for the heart -- but for the brain!]. Mmw Fortschritte Der Medizin. 150: 23. PMID 19149308  0.76
2008 Lorenzl S, Mayer S, Noachtar S, Borasio GD. Nonconvulsive status epilepticus in terminally ill patients-a diagnostic and therapeutic challenge. Journal of Pain and Symptom Management. 36: 200-5. PMID 18395399 DOI: 10.1016/j.jpainsymman.2007.10.006  0.76
2008 Lorenzl S, Buerger K, Hampel H, Beal MF. Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia. International Psychogeriatrics / Ipa. 20: 67-76. PMID 17697439 DOI: 10.1017/S1041610207005790  0.76
2008 Egidi G, Gerken M, Lorenzl S, Linnebank M, Stanger O, Diener HC. Secondary stroke prevention: Recent advances | Sekundärprävention des schlaganfalls: Was ist neu? Deutsches Arzteblatt. 105: 128-129. DOI: 10.3238/arztebl.2008.0128a  0.76
2008 Hinterberger K, Ostwald A, Löper ML, Levin J, Lorenzl S, Ziegler W. Progression and degree of severity of dysarthria in patients with progressive supranuclear palsy (PSP) and idiopathic Parkinsonism (IPS) | Verlauf und schweregrad der dysarthrie bei patienten mit progressiver supranukleärer blickparese (PSP) und idiopathischem Parkinson-syndrom (IPS) Neurologie Und Rehabilitation. 14: 247-253.  0.76
2007 Vogeser M, Lorenzl S. Comparison of automated assays for the determination of vitamin B12 in serum. Clinical Biochemistry. 40: 1342-5. PMID 17889846 DOI: 10.1016/j.clinbiochem.2007.08.004  0.76
2007 Herrmann W, Lorenzl S, Obeid R. [Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders--current evidence and preliminary recommendations]. Fortschritte Der Neurologie-Psychiatrie. 75: 515-27. PMID 17729191 DOI: 10.1055/s-2007-980112  0.76
2007 Glas M, Popp B, Angele B, Koedel U, Chahli C, Schmalix WA, Anneser JM, Pfister HW, Lorenzl S. A role for the urokinase-type plasminogen activator system in amyotrophic lateral sclerosis. Experimental Neurology. 207: 350-6. PMID 17716658 DOI: 10.1016/j.expneurol.2007.07.007  0.76
2007 Vogeser M, Müller W, Lorenzl S. External quality assessment of urinary methylmalonic acid quantification - results of a pilot study. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 45: 695-6. PMID 17484638 DOI: 10.1515/CCLM.2007.109  0.76
2007 Kiaei M, Kipiani K, Calingasan NY, Wille E, Chen J, Heissig B, Rafii S, Lorenzl S, Beal MF. Matrix metalloproteinase-9 regulates TNF-alpha and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis. Experimental Neurology. 205: 74-81. PMID 17362932 DOI: 10.1016/j.expneurol.2007.01.036  0.76
2007 Kim YS, Choi DH, Block ML, Lorenzl S, Yang L, Kim YJ, Sugama S, Cho BP, Hwang O, Browne SE, Kim SY, Hong JS, Beal MF, Joh TH. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 21: 179-87. PMID 17116747 DOI: 10.1096/fj.06-5865com  0.76
2006 Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schäfer H, Bötzel K, Daniels C, Deutschländer A, Dillmann U, Eisner W, Gruber D, Hamel W, Herzog J, Hilker R, Klebe S, ... ... Lorenzl S, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 355: 896-908. PMID 16943402 DOI: 10.1056/NEJMoa060281  0.76
2006 Lorenzl S, Narr S, Angele B, Krell HW, Gregorio J, Kiaei M, Pfister HW, Beal MF. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice. Experimental Neurology. 200: 166-71. PMID 16516196 DOI: 10.1016/j.expneurol.2006.01.026  0.76
2006 Peters N, Lorenzl S, Fischereder J, Bötzel K, Straube A. Hypnic headache: a case presentation including polysomnography. Cephalalgia : An International Journal of Headache. 26: 84-6. PMID 16396671 DOI: 10.1111/j.1468-2982.2006.01011.x  0.76
2006 Vogeser M, Müller W, Lorenzl S. External quality control of urinary methyl malonic acid quantification - announcement of a pilot study. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 44: 123-4. PMID 16375598 DOI: 10.1515/CCLM.2006.023  0.76
2006 Olzowy B, Lorenzl S, Guerkov R. Bilateral and unilateral internal carotid artery dissection causing isolated hypoglossal nerve palsy: a case report and review of the literature. European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (Eufos) : Affiliated With the German Society For Oto-Rhino-Laryngology - Head and Neck Surgery. 263: 390-3. PMID 16252123 DOI: 10.1007/s00405-005-1005-3  0.76
2004 Lorenzl S, Calingasan N, Yang L, Albers DS, Shugama S, Gregorio J, Krell HW, Chirichigno J, Joh T, Beal MF. Matrix metalloproteinase-9 is elevated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. Neuromolecular Medicine. 5: 119-32. PMID 15075439 DOI: 10.1385/NMM:5:2:119  0.76
2004 Lorenzl S, Albers DS, Chirichigno JW, Augood SJ, Beal MF. Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy. Journal of the Neurological Sciences. 218: 39-45. PMID 14759631 DOI: 10.1016/j.jns.2003.10.015  0.76
2003 Yang L, Sugama S, Chirichigno JW, Gregorio J, Lorenzl S, Shin DH, Browne SE, Shimizu Y, Joh TH, Beal MF, Albers DS. Minocycline enhances MPTP toxicity to dopaminergic neurons. Journal of Neuroscience Research. 74: 278-85. PMID 14515357 DOI: 10.1002/jnr.10709  0.76
2003 Lorenzl S, Vogeser M, Müller-Schunk S, Pfister HW. Clinically and MRI documented funicular myelosis in a patient with metabolical vitamin B12 deficiency but normal vitamin B12 serum level. Journal of Neurology. 250: 1010-1. PMID 12928928 DOI: 10.1007/s00415-003-1161-6  0.76
2003 Lorenzl S, De Pasquale G, Segal AZ, Beal MF. Dysregulation of the levels of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the early phase of cerebral ischemia. Stroke; a Journal of Cerebral Circulation. 34: e37-8; author reply . PMID 12750528 DOI: 10.1161/01.STR.0000075563.45920.24  0.76
2003 Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Beal MF. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochemistry International. 43: 191-6. PMID 12689599 DOI: 10.1016/S0197-0186(03)00004-4  0.76
2003 Lorenzl S, Albers DS, LeWitt PA, Chirichigno JW, Hilgenberg SL, Cudkowicz ME, Beal MF. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases. Journal of the Neurological Sciences. 207: 71-6. PMID 12614934 DOI: 10.1016/S0022-510X(02)00398-2  0.76
2003 Sugama S, Yang L, Cho BP, DeGiorgio LA, Lorenzl S, Albers DS, Beal MF, Volpe BT, Joh TH. Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Research. 964: 288-94. PMID 12576189 DOI: 10.1016/S0006-8993(02)04085-4  0.76
2002 Lorenzl S, Albers DS, Narr S, Chirichigno J, Beal MF. Expression of MMP-2, MMP-9, and MMP-1 and their endogenous counterregulators TIMP-1 and TIMP-2 in postmortem brain tissue of Parkinson's disease. Experimental Neurology. 178: 13-20. PMID 12460604 DOI: 10.1006/exnr.2002.8019  0.76
1998 Paul R, Lorenzl S, Koedel U, Sporer B, Vogel U, Frosch M, Pfister HW. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Annals of Neurology. 44: 592-600. PMID 9778257 DOI: 10.1002/ana.410440404  0.76
1998 Koedel U, Lorenzl S, Gorriz C, Arendt RM, Pfister HW. Endothelin B receptor-mediated increase of cerebral blood flow in experimental pneumococcal meningitis. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 18: 67-74. PMID 9428307 DOI: 10.1097/00004647-199801000-00007  0.76
1997 Pfister HW, Lorenzl S, Yousry T. Neuroradiographic manifestations of encephalitis. The New England Journal of Medicine. 337: 1393-4. PMID 9380097 DOI: 10.1056/NEJM199711063371916  0.76
1997 Koedel U, Gorriz C, Lorenzl S, Pfister HW. Increased endothelin levels in cerebrospinal fluid samples from adults with bacterial meningitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 329-30. PMID 9332538  0.76
1996 Lorenzl S, Koedel U, Pfister HW. Mannitol, but not allopurinol, modulates changes in cerebral blood flow, intracranial pressure, and brain water content during pneumococcal meningitis in the rat. Critical Care Medicine. 24: 1874-80. PMID 8917039 DOI: 10.1097/00003246-199611000-00018  0.76
1996 Lorenzl S, Ködel U, Frei K, Pfister HW. Effect of the bradykinin B2 receptor antagonist Hoe140 in experimental pneumococcal meningitis in the rat. European Journal of Pharmacology. 308: 335-41. PMID 8858309 DOI: 10.1016/0014-2999(96)00375-5  0.76
1996 Lorenzl S, Pfister HW, Padovan C, Yousry T. MRI abnormalities in tick-borne encephalitis. Lancet. 347: 698-9. PMID 8596421  0.4
1996 Lorenzl S, Pfister HW, Padovan C, Yousry T. MRI abnormalities in tickborne encephalitis [22] Lancet. 347: 698-699. DOI: 10.1016/S0140-6736(96)91256-8  0.76
1995 Lorenzl S, Koedel U, Frei K, Bernatowicz A, Fontana A, Pfister HW. Protective effect of a 21-aminosteroid during experimental pneumococcal meningitis. The Journal of Infectious Diseases. 172: 113-8. PMID 7797900  0.76
1993 Lorenzl S, Koedel U, Dirnagl U, Ruckdeschel G, Pfister HW. Imaging of leukocyte-endothelium interaction using in vivo confocal laser scanning microscopy during the early phase of experimental pneumococcal meningitis. The Journal of Infectious Diseases. 168: 927-33. PMID 7690826  0.76
1992 Pfister HW, Koedel U, Lorenzl S, Tomasz A. Antioxidants attenuate microvascular changes in the early phase of experimental pneumococcal meningitis in rats. Stroke; a Journal of Cerebral Circulation. 23: 1798-804. PMID 1448831  0.76
Show low-probability matches.